Skip to main content
Contact Us
Subscribe
E-Edition
55°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Aileron Therapeutics Inc
(NQ:
ALRN
)
6.930
UNCHANGED
Streaming Delayed Price
Updated: 11:05 AM EDT, Mar 28, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Aileron Therapeutics Inc
< Previous
1
2
3
Next >
Aileron Therapeutics Announces CEO Transition
March 12, 2024
From
Aileron Therapeutics, Inc.
Via
GlobeNewswire
Aileron Therapeutics and Pulmonary Care Experts To Discuss the Potential Implications of LTI-03 for Idiopathic Pulmonary Fibrosis in Virtual Key Opinion Leader Event
February 15, 2024
Topline results from Phase 1b study of LTI-03, Aileron’s novel Caveolin-1-related peptide in development for the treatment of idiopathic pulmonary fibrosis, expected in the second quarter of 2024
From
Aileron Therapeutics, Inc.
Via
GlobeNewswire
Aileron Therapeutics to Host Key Opinion Leader Event on February 15, 2024
February 01, 2024
Panel discussion will highlight LTI-03, Aileron’s novel Caveolin-1-related peptide, for the treatment of idiopathic pulmonary fibrosis
From
Aileron Therapeutics, Inc.
Via
GlobeNewswire
Why UPS Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
January 30, 2024
Shares of United Parcel Service, Inc. (NYSE: UPS) fell sharply during Tuesday’s session after the company reported worse-than-expected fourth-quarter sales results and issued FY24 sales
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
January 23, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
January 12, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
January 12, 2024
We're starting out the final day of trading this week with a breakdown of the biggest pre-market stock movers for Friday morning!
Via
InvestorPlace
Why Quanex Building Products Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
December 15, 2023
Shares of Quanex Building Products Corporation (NYSE: NX) moved lower during Friday’s session after the company reported fourth-quarter financial results. Quanex Building Products shares fell 10.7% to...
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
December 15, 2023
Via
Benzinga
Why Getaround Shares Are Trading Higher By Around 86%; Here Are 20 Stocks Moving Premarket
December 15, 2023
Shares of Getaround, Inc. (NYSE: GETR) rose sharply in pre-market trading after the company reported a year-over-year increase in third-quarter financial results.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
December 15, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
December 15, 2023
It's time to dive into the biggest pre-market stock movers for Friday morning as we check out the winners and losers today!
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
December 14, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
November 06, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
November 01, 2023
Via
Benzinga
Top 5 Health Care Stocks That May Collapse In Q2
May 10, 2023
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.
Via
Benzinga
Looking Into Aileron Therapeutics's Recent Short Interest
March 03, 2023
Aileron Therapeutics's (NASDAQ:ALRN) short percent of float has risen 50.0% since its last report. The company recently reported that it has 30 thousand shares sold short, which is 0.84% of all regular...
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
April 03, 2023
On Monday, 76 companies set new 52-week lows.
Via
Benzinga
S&P 500 Down 2%; Mobilicom Shares Spike Higher
February 21, 2023
U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dropping more than 2% on Tuesday. The Dow traded down 2.06% to 33,129.04 while the NASDAQ fell 2.39% to 11,506.10. The S&P...
Via
Benzinga
Why CVRx Shares Are Trading Lower By 43%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
February 21, 2023
Gainers Arbe Robotics Ltd. (NASDAQ: ARBE) gained 62.8% to $7.08. Arbe Robotics is expected to report its financial results for the fourth quarter on Thursday, March 2, 2023.
Via
Benzinga
Aileron Therapeutics Shelves Development On Chemoprotection Agent, Shares Fall
February 21, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
February 21, 2023
Via
Benzinga
Dow Tumbles More Than 500 Points; US Manufacturing PMI Rises In February
February 21, 2023
U.S. stocks traded lower midway through trading, with the Dow Jones dropping more than 500 points on Tuesday. The Dow traded down 1.61% to 33,280.92 while the NASDAQ fell 2.05% to 11,545.79. The S&P...
Via
Benzinga
Nasdaq Drops Over 100 Points; Walmart Issues Cautious Forecast
February 21, 2023
U.S. stocks traded lower this morning, with the Nasdaq Composite dropping more than 100 points on Tuesday. Following the market opening Tuesday, The Dow traded down 1.15% to 33,438.86 while the NASDAQ...
Via
Benzinga
Aileron Therapeutics Announces Termination of Phase 1b Breast Cancer Chemoprotection Trial and Exploration of Strategic Alternatives
February 21, 2023
From
Aileron Therapeutics, Inc.
Via
GlobeNewswire
Aileron Therapeutics Regains Compliance with Nasdaq Listing Requirements
November 30, 2022
From
Aileron Therapeutics, Inc.
Via
GlobeNewswire
Aileron Therapeutics Announces a 1-for-20 Reverse Stock Split
November 10, 2022
Common Stock Will Begin Trading on Split-Adjusted Basis on November 11, 2022
From
Aileron Therapeutics, Inc.
Via
GlobeNewswire
Aileron Therapeutics Reports Third Quarter 2022 Financial Results and Business Highlights
November 01, 2022
From
Aileron Therapeutics, Inc.
Via
GlobeNewswire
Aileron Therapeutics Presents Results from Phase 1 Study in Healthy Volunteers Demonstrating ALRN-6924 Induced Cell Cycle Arrest in Bone Marrow Stem Cells and Hair Follicles at EORTC-NCI-AACR International Conference
October 26, 2022
From
Aileron Therapeutics, Inc.
Via
GlobeNewswire
Aileron Therapeutics Announces Oral Presentation of Non-Clinical Data Demonstrating ALRN-6924 Protected Human Hair Follicles and Their Stem Cells from Chemotherapy-Induced Damage at the European Society for Dermatological Research Annual Meeting 2022
September 30, 2022
From
Aileron Therapeutics, Inc.
Via
GlobeNewswire
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.